These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 33640632)

  • 21. Synthesis of some novel benzofuran-2-yl(4,5-dihyro-3,5-substituted diphenylpyrazol-1-yl) methanones and studies on the antiproliferative effects and reversal of multidrug resistance of human MDR1-gene transfected mouse lymphoma cells in vitro.
    Parekh S; Bhavsar D; Savant M; Thakrar S; Bavishi A; Parmar M; Vala H; Radadiya A; Pandya N; Serly J; Molnár J; Shah A
    Eur J Med Chem; 2011 May; 46(5):1942-8. PubMed ID: 21396744
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fluorinated β-Diketo Phosphorus Ylides Are Novel Inhibitors of the ABCB1 Efflux Pump of Cancer Cells.
    Spengler G; Ocsovszki I; Tönki ÁS; Saijo R; Watanabe G; Kawase M; Molnár J
    Anticancer Res; 2015 Nov; 35(11):5915-9. PubMed ID: 26504015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. O
    Li Q; Zou P; Sun J; Chen L
    Eur J Med Chem; 2018 Jan; 143():732-744. PubMed ID: 29220794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epoxylathyrol Derivatives: Modulation of ABCB1-Mediated Multidrug Resistance in Human Colon Adenocarcinoma and Mouse T-Lymphoma Cells.
    Matos AM; Reis M; Duarte N; Spengler G; Molnár J; Ferreira MJ
    J Nat Prod; 2015 Sep; 78(9):2215-28. PubMed ID: 26331763
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovery of pyridoquinoxaline-based new P-gp inhibitors as coadjutant against Multi Drug Resistance in cancer.
    Ibba R; Sestito S; Ambrosio FA; Marchese E; Costa G; Fiorentino FP; Fusi F; Marchesi I; Polini B; Chiellini G; Alcaro S; Piras S; Carta A
    Eur J Med Chem; 2024 Oct; 276():116647. PubMed ID: 38981337
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 1-[4-(2-Aminoethoxy)phenylcarbonyl]-3,5-bis-(benzylidene)-4-oxopiperidines: a novel series of highly potent revertants of P-glycoprotein associated multidrug resistance.
    Das U; Molnár J; Baráth Z; Bata Z; Dimmock JR
    Bioorg Med Chem Lett; 2008 Jun; 18(12):3484-7. PubMed ID: 18513966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Benzophenone Sulfonamide Derivatives as Interacting Partners and Inhibitors of Human P-glycoprotein.
    Farman S; Javed A; Arshia ; Khan KM; Nasir A; Khan AU; Lodhi MA; Gul H; Khan F; Asad M; Parveen Z
    Anticancer Agents Med Chem; 2020; 20(14):1739-1751. PubMed ID: 32416700
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and evaluation of stereoisomers of methylated catechin and epigallocatechin derivatives on modulating P-glycoprotein-mediated multidrug resistance in cancers.
    Wong ILK; Wang XK; Liu Z; Sun W; Li FX; Wang BC; Li P; Wan SB; Chow LMC
    Eur J Med Chem; 2021 Dec; 226():113795. PubMed ID: 34597896
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Parguerenes: Marine red alga bromoditerpenes as inhibitors of P-glycoprotein (ABCB1) in multidrug resistant human cancer cells.
    Huang XC; Sun YL; Salim AA; Chen ZS; Capon RJ
    Biochem Pharmacol; 2013 May; 85(9):1257-68. PubMed ID: 23415901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discovery of potential anticancer multi-targeted ligustrazine based cyclohexanone and oxime analogs overcoming the cancer multidrug resistance.
    Zha GF; Qin HL; Youssif BGM; Amjad MW; Raja MAG; Abdelazeem AH; Bukhari SNA
    Eur J Med Chem; 2017 Jul; 135():34-48. PubMed ID: 28431353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quercetin-glutamic acid conjugate with a non-hydrolysable linker; a novel scaffold for multidrug resistance reversal agents through inhibition of P-glycoprotein.
    Kim MK; Kim Y; Choo H; Chong Y
    Bioorg Med Chem; 2017 Feb; 25(3):1219-1226. PubMed ID: 28043777
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structure-activity relationship study of novel 2-aminobenzofuran derivatives as P-glycoprotein inhibitors.
    Chen CY; Lin CM; Lin HC; Huang CF; Lee CY; Si Tou TC; Hung CC; Chang CS
    Eur J Med Chem; 2017 Jan; 125():1023-1035. PubMed ID: 27810590
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nitrogen-containing naringenin derivatives for reversing multidrug resistance in cancer.
    Ferreira RJ; Gajdács M; Kincses A; Spengler G; Dos Santos DJVA; Ferreira MU
    Bioorg Med Chem; 2020 Dec; 28(23):115798. PubMed ID: 33038666
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel Heat Shock Protein 90 Inhibitors Suppress P-Glycoprotein Activity and Overcome Multidrug Resistance in Cancer Cells.
    Dinić J; Podolski-Renić A; Jovanović M; Musso L; Tsakovska I; Pajeva I; Dallavalle S; Pešić M
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31527404
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery of new pyrimidopyrrolizine/indolizine-based derivatives as P-glycoprotein inhibitors: Design, synthesis, cytotoxicity, and MDR reversal activities.
    Shawky AM; Abdalla AN; Ibrahim NA; Abourehab MAS; Gouda AM
    Eur J Med Chem; 2021 Jun; 218():113403. PubMed ID: 33823396
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Isolation and Structure Elucidation, Molecular Docking Studies of Screlotiumol from Soil Borne Fungi Screlotium rolfsii and their Reversal of Multidrug Resistance in Mouse Lymphoma Cells.
    Ahmad B; Rizwan M; Rauf A; Raza M; Azam S; Bashir S; Molnar J; Csonka A; Szabo D
    Asian Pac J Cancer Prev; 2016; 17(4):2083-7. PubMed ID: 27221899
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exploration of 1,2,3-triazole-pyrimidine hybrids as potent reversal agents against ABCB1-mediated multidrug resistance.
    Wang B; Zhao B; Chen ZS; Pang LP; Zhao YD; Guo Q; Zhang XH; Liu Y; Liu GY; Hao-Zhang ; Zhang XY; Ma LY; Liu HM
    Eur J Med Chem; 2018 Jan; 143():1535-1542. PubMed ID: 29126726
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and biological evaluation of bifendate derivatives bearing 6,7-dihydro-dibenzo[c,e]azepine scaffold as potential P-glycoprotein and tumor metastasis inhibitors.
    Gu X; Jiang Y; Qu Y; Chen J; Feng D; Li C; Yin X
    Eur J Med Chem; 2018 Feb; 145():379-388. PubMed ID: 29335204
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HM30181 Derivatives as Novel Potent and Selective Inhibitors of the Breast Cancer Resistance Protein (BCRP/ABCG2).
    Köhler SC; Wiese M
    J Med Chem; 2015 May; 58(9):3910-21. PubMed ID: 25855895
    [TBL] [Abstract][Full Text] [Related]  

  • 40. N,N-bis(cyclohexanol)amine aryl esters: the discovery of a new class of highly potent inhibitors of transporter-dependent multidrug resistance (MDR).
    Teodori E; Dei S; Martelli C; Scapecchi S
    Curr Top Med Chem; 2010; 10(17):1715-31. PubMed ID: 20645921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.